In-vitro and in-vivo activity of DWC-751, a new cephalosporin.
Choi
K H
KH
College of Pharmacy, Seoul National University, Korea.
Kim
D J
DJ
Shim
J S
JS
Choi
M J
MJ
Park
N J
NJ
Kim
B O
BO
Yu
Y H
YH
Choi
E C
EC
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002439:Cefotaxime / Q000494:pharmacology; D002442:Ceftazidime / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology*; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy*; D006094:Gram-Positive Bacteria / Q000187:drug effects*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D008826:Microbial Sensitivity Tests
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; C089867:DWC 751; D002442:Ceftazidime; D002439:Cefotaxime